Appili Therapeutics Inc. (TSE:APL – Get Rating) – Equities researchers at Zacks Small Cap boosted their FY2023 earnings estimates for shares of Appili Therapeutics in a note issued to investors on Thursday, September 1st. Zacks Small Cap analyst D. Bautz now anticipates that the company will post earnings per share of ($0.09) for the year, up from their previous estimate of ($0.10).
Get Appili Therapeutics alerts:Appili Therapeutics (TSE:APL – Get Rating) last issued its quarterly earnings data on Friday, August 12th. The company reported C($0.03) earnings per share (EPS) for the quarter, hitting the consensus estimate of C($0.03). The business had revenue of C$0.01 million for the quarter.
Appili Therapeutics Stock Performance
Further Reading
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.